BlackRock’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $35.3M | Buy |
5,510,189
+3,122,780
| +131% | +$20M | ﹤0.01% | 2631 |
|
|
2025
Q1 | $8.45M | Buy |
2,387,409
+108,475
| +5% | +$384K | ﹤0.01% | 3362 |
|
|
2024
Q4 | $8.61M | Sell |
2,278,934
-269,272
| -11% | -$1.02M | ﹤0.01% | 3458 |
|
|
2024
Q3 | $8.26M | Sell |
2,548,206
-121,535
| -5% | -$394K | ﹤0.01% | 3455 |
|
|
2024
Q2 | $5.07M | Sell |
2,669,741
-1,804,981
| -40% | -$3.43M | ﹤0.01% | 3630 |
|
|
2024
Q1 | $12.7M | Buy |
4,474,722
+472,388
| +12% | +$1.34M | ﹤0.01% | 3173 |
|
|
2023
Q4 | $58.9M | Buy |
4,002,334
+426,875
| +12% | +$6.28M | ﹤0.01% | 2333 |
|
|
2023
Q3 | $65.5M | Buy |
3,575,459
+70,174
| +2% | +$1.28M | ﹤0.01% | 2217 |
|
|
2023
Q2 | $75.6M | Sell |
3,505,285
-109,633
| -3% | -$2.36M | ﹤0.01% | 2205 |
|
|
2023
Q1 | $106M | Sell |
3,614,918
-2,008
| -0.1% | -$58.9K | ﹤0.01% | 1961 |
|
|
2022
Q4 | $134M | Buy |
3,616,926
+1,321,092
| +58% | +$48.8M | ﹤0.01% | 1804 |
|
|
2022
Q3 | $64.6M | Buy |
2,295,834
+1,586,402
| +224% | +$44.7M | ﹤0.01% | 2243 |
|
|
2022
Q2 | $13.7M | Buy |
709,432
+137,091
| +24% | +$2.64M | ﹤0.01% | 3255 |
|
|
2022
Q1 | $7.35M | Buy |
+572,341
| New | +$7.35M | ﹤0.01% | 3671 |
|